Raymond James Financial Services Advisors, Inc. Integra Lifesciences Holdings Corp Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$23.14 - $34.72 $19,275 - $28,921	833 Added 13.04%	7,219 $210,000
Q1 2024 Apr 22, 2024	BUY	$33.4 - $45.2 $213,292 - $288,647	6,386 New	6,386 $226,000
Q1 2022 May 11, 2022	SELL	$62.86 - $69.24 $13.5 Million - $14.9 Million	-215,001 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$62.47 - $73.25 $13.4 Million - $15.7 Million	215,001 New	215,001 $14.4 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$267 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$184 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$125 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$99.9 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$94 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.98B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account